Market Cap (In USD)
207.03 Million
Revenue (In USD)
-
Net Income (In USD)
-
Avg. Volume
175.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 15.0-16.0
- PE
- -
- EPS
- -
- Beta Value
- 1.129
- ISIN
- US92851B1026
- CUSIP
- 92851B102
- CIK
- 1697884
- Shares
- 207030000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Jer-Li Lin
- Employee Count
- -
- Website
- https://www.vitaspringbio.com
- Ipo Date
- 2019-11-13
- Details
- VitaSpring Biomedical Co. Ltd. focuses on the development of drugs of cell medicine. The company was formerly known as Shemn Corp. and changed its name to VitaSpring Biomedical Co. Ltd. in February 2020. VitaSpring Biomedical Co. Ltd. was incorporated in 2016 and is headquartered in Irvine, California.
More Stocks
-
5930
-
RTNB
-
9534
-
4191
-
ALCIS
-
300650Tecnon Electronics Co., Ltd.
300650
-
RNLSYRenault SA
RNLSY
-
AETHERAether Industries Limited
AETHER